- Correction
- Open Access
- Published:
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Journal of Hematology & Oncology volume 13, Article number: 53 (2020)
The Original Article was published on 03 April 2020
Correction to: J Hematol Oncol 13, 30 (2020)
https://doi.org/10.1186/s13045-020-00856-8
The original article [1] contained omissions in Fig. 2, Fig. 3 & Fig. 5 which were mistakenly introduced by the production team handling this article. The original article has now been corrected to reflect the correct presentation of these figures.
Reference
Dai H, et al. Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia. J Hematol Oncol. 2020;13:30 https://doi.org/10.1186/s13045-020-00856-8.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Dai, H., Wu, Z., Jia, H. et al. Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia. J Hematol Oncol 13, 53 (2020). https://doi.org/10.1186/s13045-020-00878-2
Published:
DOI: https://doi.org/10.1186/s13045-020-00878-2